Merck & Company ( (MRK) ) has released its Q3 earnings. Here is a breakdown of the information Merck & Company presented to its ...

We recently made a list of UBS’ Best Stocks In The AI, Growth & Low Rates Era: Top 29 US Stocks. In this piece, we will take ...

Welcome to the Merck & Company Q3 sales and earnings conference call. [Operator instructions] This call is being recorded.

Belen Garijo took charge of German drug-to-semiconductor group Merck KGaA with the tailwind ... her strategy to reposition the Darmstadt-based company as a global player in oncology and immunology.

now accounting for more than a third of its total sales there has been pressure on the company to diversify. Dean Li, president of Merck Research Laboratories, told the meeting that cardiovascular ...

Analyst Terence Flynn of Morgan Stanley maintained a Hold rating on Merck & Company (MRK – Research Report), reducing the price ...

Merck’s stock fell Thursday morning, despite the company beating profit and sales estimates for the third quarter.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Jannie Oosthuizen, president, Human Health U.S., and Dr. Joerg Koglin, senior vice president and head of ...

In the latest market close, Merck (MRK) reached $106.64, with a +0.28% movement compared to the previous day. The stock's change was more than the S&P 500's daily loss of 0.05%. Meanwhile, the Dow ...

Merck & Co. Inc.'s stock fell 3% Thursday, after the drug company beat profit and sales estimates for the third quarter, but lowered guidance due to charges stemming from deals with partners Curon ...